Dose.com Unveils Smart Band-Aid to Transform Drug Delivery

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

Revolutionizing Drug Delivery and Medication Management

LAS VEGAS, Jan. 7, 2025 /PRNewswire/ — Dose.com is set to unveil its innovative smart patch system at CES 2025. Designed to resemble a simple band-aid, the Dose Patch is a highly agile drug delivery system that transforms how medications are delivered, combining convenience with precision patient monitoring.

Each Dose Patch automates medication schedules, releasing precisely timed doses directly through the skin and into the bloodstream. Acting as a “smart band-aid,” it supports a variety of treatment regimens while providing healthcare professionals with real-time data on patient adherence/compliance and progress. By simplifying medication management, Dose aims to make treatment easier for patients and more effective for clinicians. “Dose is designed to address critical challenges in medication delivery and management,” said Luke Heron, founder of Dose.com. “Our platform is designed to provide a seamless experience for patients while equipping healthcare professionals with the tools they need to deliver better care.”

The Dose Patch embodies a leap forward in drug delivery, combining precision engineering with user-friendly design. Its micro-engineered system ensures medications are delivered precisely and consistently, automating dosing schedules to maintain optimal therapeutic levels. Integrated with a companion app, the patch offers real-time insights into patient adherence, empowering healthcare providers to monitor progress and adjust treatment plans without the need for frequent in-person visits.

Designed to blend effortlessly into everyday life, the Dose Patch is intended to be as easy to use as applying a band-aid. This simplicity, paired with its advanced capabilities, positions Dose as a transformative solution for patients, clinicians and pharmaceutical companies alike, addressing the complexities of medication management while keeping care personal and effective.

About Dose

Dose is a smart transdermal patch system designed to optimize medication delivery and management. By integrating advanced dosing technology with real-time monitoring capabilities, Dose simplifies therapy for patients and healthcare providers, offering a scalable platform adaptable to a broad range of pharmaceutical applications.

About CES 2025

CES 2025 is the world’s premier technology event, showcasing groundbreaking innovations across industries. This year’s highlights include Nvidia’s highly anticipated new chip launches, Sony’s unveiling of its first electric vehicle, and a host of advancements in AI, healthcare, and sustainable technology. As the ultimate platform for innovation, CES brings together leading companies and visionary entrepreneurs to shape the future of technology and its impact on the world, with 150,000 delegates expected to attend this week.

Click here for more details about our booth at: https://ces25.mapyourshow.com/8_0/exhibitor/exhibitor-details.cfm?exhid=001Pp00000pofU1IAI.

View original content:https://www.prnewswire.com/news-releases/dosecom-unveils-smart-band-aid-to-transform-drug-delivery-302344079.html

SOURCE Dose.com

Staff

Recent Posts

NJ Rallies Investment Power, Leveraging Capital from Garden State Venture Partners to Drive MedTech and Maternal Health Innovation

GLASSBORO, N.J.--(BUSINESS WIRE)--Two transformative healthcare announcements this week mark a new era for New Jersey’s…

3 hours ago

Revival Healthcare Capital Announces Strategic Partnership to Accelerate External Innovation in Robotics With up to $458 Million Joint Investment With Olympus Into Co-Founded New Company Swan EndoSurgical

AUSTIN, Texas--(BUSINESS WIRE)--Revival Healthcare Capital (Revival), an investment firm focused on transformative external innovation partnerships…

3 hours ago

Establishment Labs to Announce Second Quarter 2025 Financial Results on August 7

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to…

6 hours ago

HCA Healthcare Reports Second Quarter 2025 Results

Raises 2025 GuidanceNASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results…

6 hours ago

Numinus Wellness Inc. Announces Fourth Quarter Fiscal 2024 Results

Q4 Fiscal 2024 Highlights1Revenue of $1.2 million, a 16.4% increase over Q3 2024Gross profit of…

6 hours ago

Phio Pharmaceuticals Announces Exercise of Warrants for Approximately $2.5 Million Gross Proceeds

King of Prussia, Pennsylvania--(Newsfile Corp. - July 25, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO),…

9 hours ago